PurMabiologics — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

PurMa Biologics LLC is a San Diego-based biotechnology company founded in 2016, operating as a manufacturer and supplier of cell culture reagents. It offers a broad catalog of over 3,000 products, including media, sera, and buffers, targeting research labs and institutions. The company emphasizes quality control, consistency, and expertise, with a focus on chemically defined media to replace variable components like fetal bovine serum. Its business model is centered on providing essential tools and consumables to the life sciences research community.

Antibodies

Technology Platform

Expertise in formulation and manufacturing of cell culture reagents, with a focus on Chemically Defined Media (CDM) to eliminate variability and contamination risks associated with serum.

Opportunities

Growing demand for consistent, serum-free, and chemically defined media from the biologics and cell therapy manufacturing sectors.

The ability to serve the niche needs of research labs with specialized media formulations and strong technical support represents a key opportunity for customer loyalty and growth.

Risk Factors

Faces intense competition from large, established life science tools conglomerates.

Operational risks include supply chain volatility for raw materials like serum and the constant need for stringent quality control across a wide product portfolio to maintain reputation.

Competitive Landscape

Operates in the highly competitive life sciences reagents market, competing directly with global giants like Thermo Fisher Scientific, Merck KGaA, and Corning, as well as many smaller specialty manufacturers. Differentiation is based on product quality, breadth of specialized media formulations, and customer service rather than price.

More companies in Biologics / Biosimilars →More companies in United States →